33 results
Pneumonia Severity Criteria - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_

#Pneumonia #Severity #Criteria #IDSA2019 #Guidelines #Inpatient #HAP
Severity Criteria - IDSA ... 2019 Guidelines ... Criteria #IDSA2019 #Guidelines ... #Inpatient #HAP ... #HCAP #Treatment
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_/

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Management Algorithm - IDSA ... 2019 Guidelines ... Algorithm #IDSA2019 #Guidelines ... #Inpatient #HAP ... #HCAP #Treatment
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Management Algorithm - IDSA ... 2019 Guidelines ... Algorithm #IDSA2019 #Guidelines ... #Inpatient #HAP ... #HCAP #Treatment
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... Aspergillosis #Treatment #pharmacology ... #medications #IDSA ... #Guidelines
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Community-Acquired Pneumonia (CAP ... fluoroquinolone #IDSA ... #Outpatient #CAP ... Regimen #Management #Guidelines ... #pharmacology
IDSA Risk Factors for Multidrug-Resistant Pathogens 

#Diagnosis #Management #InfectiousDiseases #MDRO #RiskFactors #HAP #VAP #HCAP #IDSA2016 #Guidelines
IDSA Risk Factors ... #RiskFactors #HAP ... #VAP #HCAP #IDSA2016 ... #Guidelines #Pneumonia
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... mg/kg per day) plus ... • Fluconazole plus ... Meningoencephalitis #IDSA ... #cryptococcus #HIVAIDS
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Tuberculosis - IDSA ... Guidelines # ... #medications #pharmacology ... #IDSA #Guidelines